BAY CITY CAPITAL LLC

10% owner at PONIARD PHARMACEUTICALS, INC. · on record since May 4, 2006
10% owner at VIA Pharmaceuticals, Inc. · on record since Jun 7, 2007
10% owner at ReShape Weightloss Inc. · on record since Nov 20, 2007
10% owner at Viracta Therapeutics, Inc. · on record since Apr 7, 2009
10% owner at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at INTERLOTT TECHNOLOGIES INC · on record since May 21, 2013
Former 10% Beneficial Owner at NEVRO CORP · on record since Nov 12, 2014
Director at Dermira, Inc. · on record since Oct 8, 2014
10% owner at Dermira, Inc. · on record since Oct 8, 2014
10% owner at NEVRO CORP · on record since Nov 5, 2014
Director at MADRIGAL PHARMACEUTICALS, INC. · on record since Jul 26, 2016
10% owner at MADRIGAL PHARMACEUTICALS, INC. · on record since Jul 26, 2016
10% owner at Kezar Life Sciences, Inc. · on record since Jun 28, 2018
10% owner at Xilio Therapeutics, Inc. · on record since Oct 26, 2021
10% owner at ALLEGRO BIODIESEL CORP · on record since Dec 6, 2005
10% owner at Enliven Therapeutics, Inc. · on record since Mar 16, 2020

Insider trading activity of BAY CITY CAPITAL LLC

Transactions on record: 65; since Jun 7, 2007

Open-market buys: 16; $20.1M

Open-market sells: 12; $116.5M

Companies traded: 10; last filing Dec 7, 2021

Figures computed from official regulatory filings — .

Companies where BAY CITY CAPITAL LLC has traded

6 tx · $80.5M · Dec 7, 2021
5 tx · $5M · Oct 26, 2021
9 tx · Mar 16, 2020
3 tx · $2.3M · Jun 28, 2018
2 tx · $23.6M · Jun 17, 2015
8 tx · $12.5M · Aug 25, 2014
6 tx · $2.5M · Jul 19, 2013
8 tx · $3M · Dec 16, 2010
6 tx · $28.4K · Aug 31, 2007
12 tx · $9.9M · Aug 8, 2007

Track record of BAY CITY CAPITAL LLC

Statistical track record

Free account

Open-market buys: 18

Last buy: Oct 26, 2021

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BAY CITY CAPITAL LLC

Co-insiders of BAY CITY CAPITAL LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 7, 2021	Other	-750,270	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 7, 2021	Other	-49,730	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 7, 2021	Other	-24,172	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	OtherD (derivative)	-1,437,297	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Buy	312,500	16.00 USD	$5M	conv 66ClusterUnusual size+1	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Other	151,294	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Other	665,696	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	OtherD (derivative)	-6,324,110	—	n/a (No price was disclosed in the filing)		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 1, 2020	Other	-43,537	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-845,008	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	690,232	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-61,378	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	13,148	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	AwardD (derivative)	15,457	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-281,878	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-3,220,915	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-5,372	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-16,103	—	n/a (No price was disclosed in the filing)		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 28, 2018	Other	472,229	—	n/a (No price was disclosed in the filing)		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 28, 2018	Buy	150,000	15.00 USD	$2.3M	conv 47ClusterFirst in 12mo	SEC
Kezar Life Sciences, Inc.Security delisted	Jun 28, 2018	OtherD (derivative)	-472,229	—	n/a (No price was disclosed in the filing)		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Jun 12, 2018	Sell	-274,092	287.46 USD	$78.8M	Unusual size	SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Jun 12, 2018	Sell	-5,908	287.46 USD	$1.7M		SEC
NEVRO CORPListing unverified	Jun 17, 2015	Sell	-481,457	47.94 USD	$23.1M	Unusual size	SEC
NEVRO CORPListing unverified	Jun 17, 2015	Sell	-10,378	47.94 USD	$497.5K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 7, 2021	Other	-750,270	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 7, 2021	Other	-49,730	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 7, 2021	Other	-24,172	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	OtherD (derivative)	-1,437,297	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Buy	312,500	16.00 USD	$5M	conv 66ClusterUnusual size+1	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Other	151,294	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Other	665,696	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	OtherD (derivative)	-6,324,110	—	n/a (No price was disclosed in the filing)		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 1, 2020	Other	-43,537	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-845,008	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	690,232	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-61,378	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	13,148	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	AwardD (derivative)	15,457	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-281,878	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-3,220,915	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-5,372	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-16,103	—	n/a (No price was disclosed in the filing)		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 28, 2018	Other	472,229	—	n/a (No price was disclosed in the filing)		SEC
Kezar Life Sciences, Inc.Security delisted	Jun 28, 2018	Buy	150,000	15.00 USD	$2.3M	conv 47ClusterFirst in 12mo	SEC
Kezar Life Sciences, Inc.Security delisted	Jun 28, 2018	OtherD (derivative)	-472,229	—	n/a (No price was disclosed in the filing)		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Jun 12, 2018	Sell	-274,092	287.46 USD	$78.8M	Unusual size	SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Jun 12, 2018	Sell	-5,908	287.46 USD	$1.7M		SEC
NEVRO CORPListing unverified	Jun 17, 2015	Sell	-481,457	47.94 USD	$23.1M	Unusual size	SEC
NEVRO CORPListing unverified	Jun 17, 2015	Sell	-10,378	47.94 USD	$497.5K		SEC